Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling Activity
- Current
Insider Ownership
Percentage - 14.90%
- Number Of
Insiders Buying
(Last 12 Months) - 3
- Amount Of
Insider Buying
(Last 12 Months) - $940,980.00
- Number Of
Insiders Selling
(Last 12 Months) - 3
- Amount Of
Insider Selling
(Last 12 Months) - $39,723.23
ATHA Insider Buying and Selling by Quarter
Get ATHA Insider Trade Alerts
Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.
Athira Pharma Insider Trading History
Athira Pharma Insider Trading - Frequently Asked Questions
Who is on Athira Pharma's Insider Roster?
The list of insiders at Athira Pharma includes Hans Moebius, Joseph Edelman, Kelly A Romano, Mark James Litton, Mark Worthington, Perceptive Advisors Llc, and Rachel Lenington. Learn more on insiders at ATHA.
What percentage of Athira Pharma stock is owned by insiders?
Which Athira Pharma insiders have been buying company stock?
The following insiders have purchased Athira Pharma stock in the last 24 months: Hans Moebius ($28,800.00), Joseph Edelman ($18,000,008.00), Kelly A Romano ($104,880.00), and Perceptive Advisors Llc ($7,807,297.50).
How much insider buying is happening at Athira Pharma?
Insiders have purchased a total of 1,657,935 Athira Pharma shares in the last 24 months for a total of $25,940,985.50 bought.
Which Athira Pharma insiders have been selling company stock?
The following insiders have sold Athira Pharma stock in the last 24 months: Mark James Litton ($21,412.40), Mark Worthington ($7,031.66), and Rachel Lenington ($11,279.17).
How much insider selling is happening at Athira Pharma?
Insiders have sold a total of 14,767 Athira Pharma shares in the last 24 months for a total of $39,723.23 sold.
